The global autoinjectors market is set to hit US$39.84 billion by 2033, driven by patient-centered drug delivery, digital innovation, and the rise of self-administration therapies. With chronic disease management and biologics adoption growing, convenience and safety remain key. https://www.prnewswire.com/news-releases/autoinjectors-market-size-will-hit-us-39-84-billion-by-2033--driven-by-patient-centered-drug-delivery-and-digital-innovation--datam-intelligence-302551263.html#:~:text=In%2DLanguage%20News-,Autoinjectors%20Market%20Size%20will%20hit%20US%24%2039.84%20Billion%20by%202033,and%20Digital%20Innovation%20%7C%20DataM%20Intelligence